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Abstract
Mutations in the LIM-homeodomain transcription factor LMX1B cause nail-patella syndrome, an autosomal dominant
pleiotrophic human disorder in which nail, patella and elbow dysplasia is associated with other skeletal abnormalities and
variably nephropathy and glaucoma. It is thought to be a haploinsufficient disorder. Studies in the mouse have shown that
during development Lmx1b controls limb dorsal-ventral patterning and is also required for kidney and eye development,
midbrain-hindbrain boundary establishment and the specification of specific neuronal subtypes. Mice completely deficient
for Lmx1b die at birth. In contrast to the situation in humans, heterozygous null mice do not have a mutant phenotype. Here
we report a novel mouse mutant Icst, an N-ethyl-N-nitrosourea-induced missense substitution, V265D, in the homeodomain
of LMX1B that abolishes DNA binding and thereby the ability to transactivate other genes. Although the homozygous
phenotypic consequences of Icst and the null allele of Lmx1b are the same, heterozygous Icst elicits a phenotype whilst the
null allele does not. Heterozygous Icst causes glaucomatous eye defects and is semi-lethal, probably due to kidney failure.
We show that the null phenotype is rescued more effectively by an Lmx1b transgene than is Icst. Co-immunoprecipitation
experiments show that both wild-type and Icst LMX1B are found in complexes with LIM domain binding protein 1 (LDB1),
resulting in lower levels of functional LMX1B in Icst heterozygotes than null heterozygotes. We conclude that Icst is a
dominant-negative allele of Lmx1b. These findings indicate a reassessment of whether nail-patella syndrome is always
haploinsufficient. Furthermore, Icst is a rare example of a model of human glaucoma caused by mutation of the same gene
in humans and mice.
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Introduction
Nail-patella syndrome (NPS) (OMIM 161200) is an autosomal
dominant human disease, cardinal features of which are nail
dysplasia, absent or hypoplastic patellae and abnormal elbows
along with iliac horns. In addition, about 30–40% of patients
develop nephropathy, which can progress to renal disease [1].
Open angle glaucoma is another feature of the disease that occurs
in about 30–40% of patients [2]. Mutations of the transcription
factor LMX1B have been found to be the underlying cause of NPS
[3–6]. LMX1B is a member of the LIM-homeodomain (LIM-HD)
family of transcription factors. The protein has two N-terminal
LIM domains that are involved in protein-protein interactions
followed by a homeodomain that binds to target DNA binding
sites. Disease-causing mutations range from complete gene
deletion to various frameshift, nonsense, splice and missense
mutations. The majority of missense mutations are found in the
homeodomain and the LIM domains. There is great variation in the
severity and range of phenotypes both within families that carry the
same mutation and between families that carry different mutations
in LMX1B. Several missense NPS homeodomain mutations tested in
vitro have shown no dominant-negative effect on the transcriptional
activity of wild-type protein [7,8] and consequently NPS is thought
to be a haploinsufficient disorder. Nevertheless, in a comprehensive
study of 106 NPS patients from 32 families, patients with mutations
in the homeodomain had more severe proteinurea than those
with mutations of the LIM domains, although other aspects of
NPS showed no phenotype-genotype correlation [9]. Association
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of haplotype with severity of nail dysplasia has also been reported
[10].
Knockout studies in mice have shown that Lmx1b is required
during development for dorsal patterning of the limb, the
establishment of the midbrain-hindbrain boundary, the develop-
ment of the cerebellum, for kidney development and for the
specification of certain neuronal subtypes (reviewed in [11]). Mice
that lack Lmx1b have ventralised limbs, kidney abnormalities,
calvarial bone defects and an absent cerebellum [12–14]. There
are also anterior segment eye defects [15]. Postnatal conditional
deletion experiments have shown that Lmx1b is required for
formation of the trabecular meshwork, the maintenance of corneal
integrity and transparency and loss results in corneal neovascu-
larisation [16]. Heterozygous knockout mice are apparently
normal indicating that in the mouse haploinsufficiency for Lmx1b
does not lead to mutant phenotypes [12,15]. However, heterozy-
gous knockout mice recover less well from unilateral nephrectomy
than wild-type mice, suggesting some role in adult kidney
regeneration and maintenance [17].
Here we report the identification of an Lmx1b missense
mutation, Icst, which has a dominant-negative mode of action.
In contrast to heterozygous knockout mice, heterozygous Lmx1bIcst
mice have buphthalmic (enlarged or bulging) eyes and develop a
glaucoma phenotype. In addition there is some post-natal lethality
associated with kidney defects. We demonstrate that the difference
in phenotypic consequence of the null and Icst alleles is due to
LMX1BIcst protein acting in a dominant-negative manner. These
findings have implications for the interpretation of the mode of
action of mutant LMX1B in NPS.
Results
Icst is a missense mutation of the Lmx1b gene
We identified the N-ethyl-N-nitrosourea-induced mouse muta-
tion, iris-corneal strands (Icst), in a screen for dominant eye
mutations. Mice that carry Icst have buphthalmic eyes suggestive
of high intra-ocular pressure [18]. We had previously mapped Icst
to proximal Chr 2 between the markers D2Mit365 and D2Mit372
[18]. Within this interval we considered Lmx1b to be a strong
candidate for harbouring the Icst mutation because glaucoma
occurs in about 30–40% of NPS patients [2]. We amplified and
sequenced the exons and flanking regions of Lmx1b from Icst
mutant mice and found a single nucleotide change, a T to A
transversion in exon 5 in the Icst allele (position 2:33,566,910 in
Ensembl Release 74 mouse assembly GRCm38 (http://www.
ensembl.org)) which was absent from the reference mouse
sequence and an additional 17 mouse strains [19] (Figure 1A).
This mutation causes substitution of hydrophobic valine with
hydrophilic aspartic acid in the homeodomain (V265D). The
affected valine is in the recognition helix, and is very highly
conserved across species and paralogues. In the crystal structure of
the related paired-type homeodomain, the equivalent valine
directly contacts the DNA recognition sequence by making
hydrophobic contacts with the second thymine in the TAAT core
of the recognition sequence [20]. The nature of the mutation in
Lmx1b, coupled with the complementation tests described below,
indicate that Icst is the causative mutant allele; Lmx1bIcst.
Examination of the sequence traces of RT-PCR products
spanning exon 5 of Lmx1b from embryonic samples indicated that
equal amounts of mutant and wild-type transcript are produced in
heterozygotes (data not shown).
We asked whether the mutant LMX1BIcst protein was able to
bind to its recognition sequence. We produced recombinant His-
tagged full-length LMX1B protein (S form, see below) and the
homeodomain alone, in both wild-type and Icst mutant versions,
and used these in bandshift experiments to determine if they could
bind to a known LMX1B recognition sequence from intron 1 of
the Col4a4 gene [21]. Both wild-type full-length and homeodomain
proteins bound but the LMX1BIcst proteins did not (Figure 1B).
We then investigated the ability of wild-type and mutant LMX1B
protein to transactivate transcription in a reporter assay. We tested
two isoforms of the mouse LMX1B protein, a 372 amino acid
protein (S) and a longer form (L) that includes an additional 29 N-
terminal amino acids initiating from an upstream AUG (see
Materials and Methods) [22]. Much of this additional sequence is
conserved between humans and mouse but also includes a direct
18 bp repeat encoding a further six amino acids. We introduced
the Icst mutation into the two isoforms and tested the ability of the
wild-type and mutant versions to transactivate a luciferase
reporter, previously shown to be activated by LMX1B, which
has six copies of the LMX1B recognition sequence upstream of a
minimal promoter [21]. Both L and S wild-type proteins
transactivated the luciferase reporter construct on co-transfection,
but neither of the LMX1BIcst proteins showed any transactivation
activity (Figure 1C). These results showed that the Icst mutation
disrupts the ability of the LMX1B protein to recognise and bind to
its target sequences and activate transcription.
Heterozygous Lmx1bIcst eye phenotype is a model of
glaucoma
Mice that are heterozygous for the Lmx1b knockout allele do not
have an eye phenotype (Figure 2A) [15]. In contrast, we observed
that the eyes of Lmx1bIcst/+ mice had mild corneal opacity at a
young age and by six to eight weeks Lmx1bIcst/+ eyes are
buphthalmic and display a variety of abnormalities, as previously
described [18]. Examples are shown in Figure 2B and 2C. Strands
of tissue extend between the iris and cornea in some mice
(Figure 2B) and corneal neovascularisation is seen, often associated
with corneal ulcers (Figure 2C). Other abnormalities in the cornea
included scarring and inflammation, with wrinkling of Descemet’s
membrane and flattening of the endothelial cells with migration
onto the anterior iris surface (Figure 2E). It is likely that endothelial
abnormalities contributed to the development of corneal oedema
(Figure 2F) and ocular surface compromise which in some cases
Author Summary
Nail-patella syndrome is a human genetic disease caused
by an inactivating mutation in one copy of a gene called
LMX1B, with the amount of protein produced from the
remaining copy of the gene not being enough for normal
function. Patients with this disease have malformations of
their nails, elbows and kneecaps. Some patients also
develop kidney disease and glaucoma. LMX1B controls
where and when other genes are expressed and it is
important during development. Studies in mice have
shown that complete absence of Lmx1b is lethal at birth. In
contrast to humans, mice with only one copy of the gene
are normal. Here we describe a new mutant mouse, Icst,
which has a mutation in Lmx1b that abolishes the ability of
the protein to bind near genes that it controls. Mice with
one normal and one copy of Lmx1b with the Icst mutation
have eye defects and some die shortly after birth probably
due to kidney failure. Therefore having one functional and
one mutant copy of Lmx1b is more detrimental than
having a half dose of functional protein. The Icstmouse is a
model of human glaucoma where mutation of the same
gene causes glaucoma in humans and mice.
A Dominant-Negative Mutation of Lmx1b
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led to ulceration. Many Lmx1bIcst/+ eyes develop severe corneal
ulcers with age. The bulging and distended appearance of the eyes
suggested that there might be dysfunction of the drainage system
at the iridocorneal angle resulting in raised intraocular pressure.
We examined the angle by histology and found abnormalities that
varied between eyes. In some Lmx1bIcst/+ eyes there was an open
angle (Figure 2H) but in other cases the angle was closed with the
iris adhering to the cornea (Figure 2I and 2J). Although the angle is
still open in some eyes, it is often narrow and sometimes
Schlemm’s canal appears abnormally short (Figure 2L). The
trabecular meshwork, a structure dependent on Lmx1b for its
development [16], typically appears abnormal, often being
compressed and hypomorphic (Figure 2L). In line with these
histological observations, we found that intraocular pressure (IOP)
was elevated in Lmx1bIcst heterozygotes (Figure 3). Between the
ages of two and six months IOP was elevated in Lmx1bIcst
heterozygotes compared to wild-types (Figure 3A). The mean IOP
measurements in older mice at 6–12 months are not statistically
different between the two groups, in part due to an increased
incidence of low IOP values (,10 mmHg) in older Lmx1bIcst
heterozygotes, which is caused by significant corneal damage
(ulceration, sometimes with inflammation and perforation).
Overall, about 35% of Lmx1bIcst heterozygotes were found to have
high IOP as compared to about 5% of wild-types (Figure 3B).
Higher IOP is most commonly associated with poorly understood
abnormalities of the iridocorneal angle [23] and it is a common
and important risk factor for developing glaucoma in humans and
can lead to the neurodegenerative hallmarks of the disease which
are retinal ganglion cell loss and optic disc cupping. We observed
optic nerve cupping in some, but not all, Lmx1bIcst heterozygous
mice at various ages (Figure 4A). There was also a profound
reduction in the number of retinal ganglion cells in Lmx1bIcst
heterozygous mice that was not seen in Lmx1bKO heterozygous
mice (Figure 4B). In addition, in Lmx1bIcst heterozygous mice optic
nerve damage occurs and the loss of axons appear to be
progressive (Figure 4C).
Lmx1bIcst is a dominant semi-lethal allele of Lmx1b
Homozygous knockout mice that lack LMX1B die on the day of
birth [12]. They have ventralised limbs, absent cerebellum and
kidney and eye defects [12,14,15]. We intercrossed heterozygous
Lmx1bIcst mice and collected offspring for genotyping at E17.5 and
at weaning. At E17.5 the three expected genotypes were present at
Mendelian ratios indicating that Lmx1bIcst does not cause lethality
in utero (Table 1). However, no Lmx1bIcst homozygous mice were
present at weaning and four pups that were dead at birth were
found to be homozygotes (Table 1). We examined homozygous
mutant embryos and observed a phenotype very similar to that
described for the knockout. Lmx1bIcst homozygotes lack a
cerebellum, have abnormal kidneys and ventralised limbs (Figure
S1 and Figure 5D). We expected this cross to produce twice as
many Lmx1bIcst heterozygotes as wild-type. However, at weaning
we found equal numbers of these genotypes, indicating a deficit of
heterozygotes and suggesting that the Icst allele is semi-lethal
Figure 1. Icst is a homeodomain missense mutation of Lmx1b
that abolishes protein function. (A) Genomic DNA sequence traces
from Lmx1b exon 5 from wild-type (WT), heterozygous mutant (Icst/+)
and homozygous mutant (Icst/Icst) embryonic samples. The position of
the T-to-A transversion at position 725 (725T.A) in the Lmx1b gene,
numbering from Genbank entry AF078166, is highlighted. This
transversion causes a V265D mutation in the homeodomain numbering
from entry O88609 in http://www.uniprot.org. (B) The Icst mutation
impairs binding of LMX1B. Bandshift analysis using a fixed amount of
32P-labelled FLAT LMX1B binding element [21] with increasing amounts
(as indicated by the triangles) of His-tagged fusion proteins containing
the homeodomain or full-length LMX1B either wild-type (WT) or
containing the Icst mutation (ICST). In lane 1 no protein was added (-).
Complexes as indicated by the arrows were formed with the wild-type
proteins but not the proteins containing the Icst mutation. The position
of the probe alone is also indicated by an arrow. (C) The Icst mutation
abolishes transcriptional activity. A luciferase reporter plasmid, 66FLAT-
C2P-Luc4, containing six copies of the LMX1B binding element FLAT
upstream of the Col2a1 promoter ([21], kind gift of Brendan Lee), was
either transfected alone (-) or co-transfected with empty pcDNA-3.1
vector (V) or pcDNA-3.1 containing the wild-type (WT-L) or Icst (Icst-L)
long form of LMX1B or wild-type (WT-S) or Icst (Icst-S) short form of
LMX1B. Each experiment was performed in triplicate, and mean firefly
luciferase expression normalized to control renilla luciferase expression
is shown+standard error. Both WT-L and WT-S elicit robust induction of
luciferase expression that reduced to background levels by the Icst
mutation (t-test; * = P,0.005).
doi:10.1371/journal.pgen.1004359.g001
A Dominant-Negative Mutation of Lmx1b
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Figure 2. Icst causes defects in the anterior segment of the eye. (A) Lmx1bKO/+ (KO/+) eye that is of normal appearance. (B) Lmx1bIcst/+ (Icst/+)
eye where there is a fine strand between the pupillary margin and the cornea (arrowed). (C) This Lmx1bIcst/+ eye is enlarged with severe corneal
vascularisation and central opacity. (D–F). Histological appearance of corneas. (D) Wild-type normal cornea (WT). (E) Lmx1bIcst/+ cornea that has
stromal vascularisation (barbed arrows). Descemet’s membrane is wrinkled (dashed arrows) and a membrane is present on the anterior surface of the
iris (arrowheads). (F) Lmx1bIcst/+ cornea with basal epithelial oedema (dashed arrow). A stromal blood vessel with red blood cells is indicated by a
barbed arrow. (G) Normal wild-type iridocorneal angle. (H–J) Iridocorneal angle morphology of Lmx1bIcst heterozygotes display a spectrum of
phenotypes ranging from open-angle (H) to closed-angle morphology where the iris can be seen adhering to the cornea and blocking the
iridocorneal angle as indicated by bars (I, J). (K–L) Higher magnification of wild-type (K) and Lmx1bIcst/+ (L) iridocorneal angles. (K) The wild-type has an
open-angle with robust drainage structures ([). Schlemm’s canal (arrowheads) is clearly identifiable and the trabecular meshwork (asterisks) has well-
formed trabecular beams. (L) The Lmx1bIcst/+ iridocorneal angle is open but narrow. Iridocorneal strands (IS) are present. These are a normal feature of
the mouse angle but are not present at all locations and do not prevent aqueous humor drainage. The drainage structures are not as robust as in the
WT ([). Schlemm’s canal is present but compressed (arrowheads) and the trabecular meshwork is hypoplastic (asterisks). Original magnification640
(D and F) and620 (E). Scale bar = 50 mm.
doi:10.1371/journal.pgen.1004359.g002
A Dominant-Negative Mutation of Lmx1b
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(Table 1). We also crossed heterozygous Lmx1bIcst mice with mice
heterozygous for the knockout allele Lmx1btm1Rjo (hereafter,
Lmx1bKO) and genotyped their offspring at weaning (Table 2).
No double mutant mice were seen among 104 offspring, indicating
that the two alleles do not complement each other and are thus
allelic. There was a deficiency of about a third of Lmx1bIcst
heterozygotes compared to Lmx1bKO heterozygotes, but this fell
short of statistical significance (x2 = 3.358, d.f. = 1, P = 0.067). To
investigate this apparent dominant lethality further, we back-
crossed both alleles of Lmx1b to C57BL/6J (Table 2) and
genotyped the offspring. We found the expected 1:1 ratio of
heterozygotes to wild-type for the Lmx1bKO allele backcross
whereas for the Lmx1bIcst allele a third fewer than expected
heterozygotes were seen (x2 = 26.3, d.f. = 1, P,0.0001). All of the
mice carrying the Icst mutation had abnormal eyes showing that
the mutant eye phenotype, as described in the previous section, is
completely penetrant on the studied genetic backgrounds. The
Figure 3. The IOP is elevated in Lmx1bIcst/+ mice. (A) Box plot of
IOP measurements of wild-type (WT) and Lmx1bIcst/+ (Het) mice taken at
different ages. There is significantly elevated IOP in the Lmx1bIcst/+ mice
up to 6 months (P = 0.006 at 2–3 months and P= 0.009 at 5–6 months).
The IOP measurements are not significantly different in older mice
owing to low readings of ,10 mmHg in increasing numbers of the
Lmx1bIcst/+ mice. (B) Frequency histogram summarizing the data from
panel A showing increased incidence of high IOP measurements in
Lmx1bIcst/+ mice.
doi:10.1371/journal.pgen.1004359.g003
Figure 4. Icst causes defects of the optic nerve and the ganglion
cell layer of the retina. (A) Sections through the optic nerve of adult
mice. The optic nerve is variably affected in Lmx1bIcst/+ mice. Wild-type
(WT) is normal (upper panel, left). In some Lmx1bIcst/+ (Icst/+) mice the
optic nerve appears normal (lower panel, left) but in others there is
evidence of optic nerve damage and cupping, indicated by asterisks
(upper and lower panels, right). Scale bar = 50 mm. (B) Box plot of
ganglion cell number present in Lmx1bIcst/+ (Icst/+), Lmx1bKO/+ (KO/+)
and wild-type (WT) mice. Ganglion cells were stained using an anti-
BRN3 antibody and the number present in each of four areas from
around the optic disc from one eye were counted (n = 3 for Lmx1bIcst/+
and n=2 for the other two genotypes). Compared to wild-type and
Lmx1bKO/+ mice which show no difference (P = 0.95) the number of
ganglion cells is greatly reduced in the Lmx1bIcst/+ mice compared to
A Dominant-Negative Mutation of Lmx1b
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observed deficiency in the number of Lmx1bIcst heterozygotes
indicates that the Lmx1bIcst allele is semi-lethal when heterozygous,
in contrast the knockout allele which does not elicit a heterozygous
phenotype. Therefore the mutant LMX1BIcst protein must exert a
dominant effect during development and/or early postnatal life
that always results in ocular abnormalities and can be lethal.
Lmx1bIcst can cause glomerular defects when
heterozygous
When and why do 30% of Lmx1bIcst heterozygous mice die? The
deficiency of Lmx1bIcst/+ mice at weaning (Table 2) was present at
P1 (x2 = 3.922, d.f. = 1, P= 0.048) (Table 3) suggesting the lethality
is perinatal and any Lmx1bIcst/+ mice that reach P1 survive as well
as their wild-type littermates. We considered a possible cause of
death to be kidney failure because of the importance of LMX1B in
podocyte and slit diaphragm development [21,24,25]. We
examined by electron microscopy the glomerular morphology of
wild-type, Lmx1bIcst heterozygous and homozygous mice and, for
comparison, glomeruli from Lmx1bKO heterozygous and homozy-
gous mice at E17.5 and E18.5 (Figure 5). We took care to examine
only the most mature glomeruli so that our analysis would not be
confounded by comparing immature and mature podocytes. Both
wild-type and Lmx1bKO heterozygous morphology was normal and
no abnormalities were found (Figure 5A and 5B) whereas in the
homozygous glomeruli the podocytes were effaced on the
glomerular basement membrane (GBM) as previously reported
(Figure 5C) [24,25]. In Lmx1bIcst homozygotes, podocytes appeared
undeveloped; the morphology resembling that seen in the
knockout (Figure 5D). We also found glomerular abnormalities
in all Lmx1bIcst/+ embryos examined although the degree varied
between individuals (Figure 5 E–L). In glomeruli from two
Lmx1bIcst/+ E17.5 embryos there was normal development in many
areas with foot processes forming normally (Figure 5E). However,
we found various abnormalities in both, representative examples
are shown in Figure 5 F–I. In Figure 5F and 5H the GBM is split.
In Figure 5F the podocyte is positioned flush against the GBM and
foot processes have failed to develop and the GBM itself is
fragmented, suggesting it is not adhering properly. In some
glomeruli podocytes were immature and cuboidal in shape
(Figure 5I). These two individuals might have been Icst heterozy-
gotes which would have survived as the ultrastructural changes are
not extensive. In another Lmx1bIcst heterozygote examined at
E18.5 there was extremely abnormal morphology (Figure 5 J–L).
The GBM is split (Figure 5J and 5K) and only some rudimentary
foot process formation was observed (Figure 5J). Areas where
podocytes were effaced onto a split GBM were also found
(Figure 5L). As we found no evidence of normal glomerular
development in this individual it is likely to be an example of one
of the Lmx1bIcst heterozygotes which would die. This variability in
the extent of the mutant kidney phenotype found in Lmx1bIcst
heterozygotes is consistent with the finding that only one third of
the Lmx1bIcst heterozygotes fail to survive.
Transgenic rescue of Lmx1bIcst and Lmx1bKO mutant
phenotypes
We have shown above that Lmx1bIcst induces gain-of-function
heterozygous phenotypes of the eye and the kidney that are not
found in heterozygotes for the knockout allele. Both alleles are
homozygous lethal at birth. To investigate if wild-type Lmx1b
could rescue these phenotypes we made mice that were transgenic
for a bacterial artificial chromosome, RP23-305A12, which
contains the Lmx1b gene centrally located in a 225 kb insert
(Tg(RP23-305A12), hereafter BAC). This transgene was intro-
duced into both the Lmx1bIcst and Lmx1bKO lines and mice crossed
to assess if it could rescue the mutant phenotypes. First we
examined the effect of the transgene on the Icst heterozygous and
homozygous phenotypes. When hemizygous, the transgene
rescued the Lmx1bIcst heterozygous gross eye phenotype (Figure
S2). However, the hemizygous transgene did not rescue the
perinatal lethality affecting Lmx1bIcst homozygotes (Table 4). In
contrast, the hemizygous transgene could rescue the perinatal
lethality of the homozygous knockout allele, although the number
of Lmx1bKO homozygous rescued pups was low and they were small
in size with ventralised limbs (see below) (Table 4). Interestingly,
variable rescue of the eye phenotype of transgenic Lmx1bKO
homozygous mice was observed; although the majority of eyes
were normal, some eyes were very abnormal, with damaged
corneas and optic nerve heads (Figure S3).
We next asked if increasing the dose of transgenic Lmx1b could
better rescue the mutant phenotypes (Table 5). We found that two
copies of the transgene could rescue the Lmx1bIcst heterozygous
semi-lethality; transgenic Lmx1bIcst heterozygotes survived in the
normal Mendelian ratio. Two BAC copies could also rescue the
homozygous perinatal lethality, albeit inefficiently (Table 5). The
Lmx1bIcst/Icst rescued mice were smaller than their littermates and
had the Icst mutant eye phenotype (Figure S4). For the knockout
allele, a greater number of homozygous Lmx1bKO mice survived
when the transgene was homozygous than when it was hemizy-
gous (Table 5) and in most cases the eyes are grossly normal.
Nevertheless, a few did have a mutant eye phenotype and in these
cases expression of wild-type Lmx1b from the transgenic BAC was
reduced (Figure S4).
All the rescued mice, whether Lmx1bKO/KO or Lmx1bIcst/Icst, had
skeletal and limb defects (Figures 6 and 7). Lmx1bIcst/Icst mice
homozygous for the transgene had paws that were clearly
ventralised; the dorsal surfaces were largely devoid of hair and
had thickened skin pads superficially, much like the ventral
surface, although the skin was pigmented (Figure 6). Lmx1bKO/KO
mice rescued by a hemizygous BAC transgene had the same
ventralisation phenotype which was not substantially improved
when the transgene was homozygous (Figure 6). However, when
we examined the skeletons of these homozygous transgenic rescue
mice by X-ray computed microtomography (mCT), we found that
aspects of the skeletal phenotype had been rescued (Figure 7). The
paw skeleton of Lmx1bIcst/Icst mice homozygous for the BAC
transgene was ventralised, as was that of Lmx1bKO/KO mice
hemizygous for the BAC transgene (Figure 7). When homozygous
the BAC transgene largely rescued the paw skeleton to near wild-
type in Lmx1bKO/KO mice, despite the ventralised surface (Figure 7).
Other skeletal abnormalities were also differentially rescued.
Amongst other skeletal defects in homozygous Lmx1bKO mice the
patella is absent and the scapula is very small [12]. We find the
same defects in homozygous Lmx1bIcst embryos (Figure S1 and data
not shown), and absence of patella is, of course, a cardinal feature
of NPS in human patients [1]. Lmx1bIcst heterozygotes (and
Lmx1bKO heterozygotes) do have patellae (data not shown). When
homozygous, the BAC transgene does not rescue the patellar and
wild-type (P = 0.017) and to Lmx1bKO/+ mice (P = 0.034). (C) Optic nerve
damage in Lmx1bIcst/+ mice. Optic nerve damage was assessed in wild-
type (WT) and Lmx1bIcst/+ (Icst/+) mice at 8 months (WT, n = 23 and Icst/+
, n = 16) and at 10–11 months (WT, n = 26 and Icst/+, n = 36). Nerves with
no glaucoma have axon counts that match controls (green bar). Nerves
with moderate nerve damage have an average of 30% axon (yellow
bar). This degree of damage occurs in a low percentage of wild-type of
this strain background at this age [59]. All severely affected nerves have
extensive axon damage throughout the optic nerve with obvious axon
loss ranging from 50% to almost complete axon loss (red bar).
doi:10.1371/journal.pgen.1004359.g004
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Figure 5. Ultrastructural analysis of E17.5 and E18.5 kidneys shows that Icst causes glomerular defects when heterozygous. (A–B)
Wild-type (WT) and Lmx1bKO/+ (KO/+) podocytes are normal with normal foot process formation (arrowheads). (C–D) Lmx1bKO/KO (KO/KO) and
Lmx1bIcst/Icst (Icst/Icst) podocytes fail to form foot processes and appear immature. (E–L) Lmx1bIcst heterozygous podocytes (Icst/+). (E) Normal foot
process formation (arrowheads). (F) The bar indicates an area of the GBM that appears fragmented. (G–H) Foot processes (arrowheads) abut GBM that
A Dominant-Negative Mutation of Lmx1b
PLOS Genetics | www.plosgenetics.org 7 May 2014 | Volume 10 | Issue 5 | e1004359
scapular defects in Lmx1bIcst/Icst mice (Figure 8B and 8E) but does
in Lmx1bKO/KO mice (Figure 8C and 8F), again demonstrating that
mutant phenotypes can be rescued more readily from the null
background than when LMX1BIcst protein is present.
These BAC transgenic experiments demonstrate that a higher
level of wild-type Lmx1b expression (i.e. two BAC copies) is
required to elicit rescue of the Lmx1bIcst mutant phenotype than the
Lmx1bKO mutant phenotype. This is consistent with an Lmx1bIcst
pathogenic mechanism with the LMX1BIcst protein exerting a
dominant-negative effect on co-expressed wild-type protein.
Mechanism of the dominant-negative effect of the
Lmx1bIcst allele
How does the LMXIBIcst mutant protein exert this dominant-
negative effect on the wild-type protein? LMX1B does not
homodimerise [26,27]. Along with other LIM-HD proteins,
LMX1B binds to co-factors via the two LIM domains [28]. One
such co-factor is LDB1 which can itself homodimerise thus
enabling the formation of homomeric or heteromeric LIM-HD
complexes [27]. This raises the possibility that complexes
containing both wild-type and mutant LMX1B could be formed
in Lmx1bIcst heterozygous mice thus decreasing the level of
functional complexes below that found in Lmx1bKO heterozygous
mice. To test if such complexes can be formed we transfected cells
with Myc-tagged wild-type LMX1B and FLAG-tagged LMX1BIcst
either alone or together and immunoprecipitated using anti-Myc
antibody. As expected the Myc-tagged wild-type LMX1B was
present in the immunoprecipitated fraction but the FLAG-tagged
LMX1BIcst was not, confirming that LMX1B indeed does not
homodimerise (Figure 9A). When LDB1 was included in the
transfections, LDB1 was co-immunoprecipitated with the wild-
type protein showing that LMX1B binds to LDB1 as expected
(Figure 9B). When all three proteins were present, FLAG-tagged
LMX1BIcst protein was co-immunoprecipitated with the wild-type
LMX1B (Figure 9B) showing that complexes containing both wild-
type and mutant LMX1B are formed where the interaction is
mediated by LDB1. Consistent with this, less LDB1 appears to be
in the bound fraction when FLAG-tagged LMX1BIcst was
included along with the Myc-tagged wild-type LMX1B, probably
due to competition between the wild-type and mutant protein for
binding to LDB1 (Figure 9B).
Discussion
Icst is a dominant-negative mutation in Lmx1b
The Icst mutation, V265D, in the homeodomain of LMX1B
abolishes DNA binding and transcriptional transactivation
(Figure 1). Whilst heterozygous null (knockout allele) Lmx1b mice
are phenotypically normal [12,15] and present in Mendelian
numbers (Table 2), a fraction of Lmx1bIcst heterozygous mice die
with associated kidney GBM defects (Table 2 and Figure 5). No
morphological abnormalities have been found in glomeruli of
Lmx1bKO heterozygotes up to one year of age [24]. Those Lmx1bIcst
heterozygotes that do survive have a highly penetrant eye
phenotype which is not seen in Lmx1bKO heterozygotes
(Figures 2–4). Depletion of Lmx1b expression in adult mice causes
corneal opacity and neovascularisation indicating that a threshold
level of Lmx1b expression in the cornea is necessary for the
maintenance of corneal integrity [16]. These differences between
the Icst and knockout heterozygous phenotypes indicate that the
LMX1BIcst protein exerts a dominant-negative effect on the wild-
type protein. Dominant-negative mutant activity is typically
mediated via protein complexes, usually dimers or higher-order
structures, in which participation of one non-functional subunit
inactivates the complex [29–33]. As previously reported [26,27]
and confirmed by our results (Figure 9) LMX1B does not
homodimerise. We have shown that both wild-type LMX1B and
LMX1BIcst proteins are found in protein complexes mediated by
LDB1 (Figure 9). Complexes containing both wild-type and Icst
mutant protein are likely to be non-functional and in Icst
heterozygotes the level of functional complexes containing only
wild-type protein would be 25%, compared to 50% in the null
heterozygotes. This provides an explanation for the difference in
the heterozygous phenotype of the two alleles and leads to the
prediction that missense mutation in the LIM domains abolishing
protein-protein interactions would be equivalent to null alleles.
LMX1B has been shown to interact with LDB1 by yeast two-
hybrid experiments [34] and complexes containing both proteins
have been detected in rat glomeruli protein lysates [35]. The two
genes have overlapping expression patterns [35,36]. In support of
the role of LDB1 in LMX1B function, in mice specific inactivation
of Ldb1 in podocytes leads to gradual loss of foot processes and
GBM defects are found which lead to renal failure [35]. However,
other binding partners for LMX1B are known, for example TCF3
[37,38] raising the possibility that proteins other than LDB1 may
be responsible for mediating the dominant-negative effect in some
cell types.
Differences in response to LMX1B mutations in humans
and mice
There is a broad spectrum of disease severity both within and
between NPS families and no clear genotype–phenotype correla-
tion between the nature of mutations and severity of disease
although in all cases skeletal abnormalities are found [5]. It is
is split (arrows). (I) The podocytes appear cuboidal (as indicated by asterisks) and immature. (J) The GBM is split as indicated by the bar and foot
processes are rudimentary (arrows). (K) There is a large split in the GBM that is filled with fibrillar material (as indicated by an asterisk). (L) Podocytes
are positioned flush against a split GBM. P, podocyte; endo= endothelial cell. Scale bar = 2 mm.
doi:10.1371/journal.pgen.1004359.g005
Table 1. Genotyping results for Lmx1bIcst/+ intercross.
Age WT Icst/+ Icst/Icst Total Pa
adult 25 25 0 50 ,0.0001
found dead at birth 1 1 4 6 0.059
E17.5 4 16 4 24 0.264
aTest for significance using Chi-square test.
doi:10.1371/journal.pgen.1004359.t001
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widely believed to be a haploinsufficient disorder and indeed,
patients with a complete deletion of LMX1B have been found [6].
Variability in disease manifestation in patients with the same
mutation is often observed [39] indicating genetic background
modification. Furthermore, mutation of LMX1B does not always
result in NPS. Two groups have reported the detection of novel
missense mutations affecting R246 in the homeodomain of
LMX1B in patients with isolated renal disease. In one report a
patient with nail-patella-like renal disease was found to have an
R246Q mutation that has residual transcription activity [40]. In
the other report patients with autosomal dominant focal and
segmental glomerular sclerosis either with the same R246Q
mutation or with a different mutation affecting the same amino
acid, R246P, were described [41]. None of the patients had any of
the other classic symptoms of NPS. The reason why in these
patients malformations are confined to the kidney is not clear. It
may be that the residual activity of the R246Q protein is sufficient
for normal development outwith the kidney or that these
mutations of R246 only compromise binding to a subset of target
sequences.
The lack of phenotype in Lmx1b null heterozygous mice [12,15]
contrasts with heterozygous Lmx1bIcst mice which have a strongly
penetrant eye phenotype and have glomerular abnormalities that
resemble defects found in human NPS patients (Figure 5). They do
not, however, have any skeletal abnormalities, which is the most
prevalent aspect of NPS. Valine 265 in LMX1B, the equivalent
residue to that mutated in the mouse Lmx1bIcst allele, has been
found mutated in NPS patients to phenylalanine and to leucine
[8,22]. V265L (originally reported as V242L) along with other
patient missense mutations have been tested for dominant-
negative effects on wild-type protein in in vitro transcription
reporter assays but none have been found [7,8]. Likewise, we have
been unable to find, in in vitro experiments, a dominant-negative
effect of the LMX1BIcst protein on transcriptional reporter assays
(data not shown), although it is clearly demonstrated by the
phenotype in mice. It is apparent that mutant proteins can show
dominant-negative activity in mice that is not seen in vitro and it is
possible that some of the human LMX1B mutations may be
dominant-negative. Indeed, it has been reported that patients with
homeodomain mutations exhibit more severe proteinuria, and
hence kidney defects, than patients with mutations in the LIM
domains suggesting dominant-negative activity [9].
Icst is a model for human glaucoma
Glaucoma is usually associated with high IOP caused by
dysfunction of the ocular drainage structures in the iridocorneal
angle of the eye [23]. LMX1B mutations are well established to
cause open-angle glaucoma in NPS patients, but due to the
influence of modifier genes may also cause glaucoma without NPS.
Although confirmation is required, LMX1B haplotype has been
suggested to influence open-angle glaucoma in the general
population (without other aspects of NPS) [42]. Similar to some
of the Lmx1bIcst heterozygous mice, a narrow but open-angle
phenotype with high IOP is present in some individuals with an
LMX1B mutation [4]. The aetiology of IOP elevation in glaucoma
remains poorly understood and it is likely to be mechanistically
heterogeneous at the molecular level. Various studies have
reported open-angle glaucoma phenotypes in mice [43–47].
However, in most cases and due to undefined multifactorial
influences, these phenotypes have typically been mild or have not
yet proven reproducible between laboratories.
Lmx1bIcst/+ mice have variably open or closed angles, and may
be amodel of anterior segment dysgenesis leading to high IOP, rather
than primary open angle glaucoma. Nevertheless they should provide
a valuable mouse model of glaucoma caused by dominant point
mutation in a gene that also causes a form of human open-angle
glaucoma. The phenotype is highly penetrant and reproducible in
our colonies at different institutions. Thus, the Icstmutation provides
a new tool for dissecting the molecular and pathologic features of IOP
elevation and glaucoma, and for testing new therapies.
Table 2. Genotyping results for backcross and intercross of the two Lmx1b alleles.
Number of offspring at weaning Pa
Cross WT Icst/+ KO/+ KO/Icst
Lmx1bIcst/+6wild-type 386 256 - - ,0.0001
Lmx1bKO/+6wild-type 67 - 64 - 0.793
Lmx1bIcst/+6Lmx1bKO/+ 37 26 41 0b ,0.0001
aTest for significance using Chi-square test.
b4 pups found dead at birth with ventralised limbs.
- = not possible genotypes.
doi:10.1371/journal.pgen.1004359.t002
Table 3. Survival of Lmx1bIcst/+ compared to wild-type at P1 in an Lmx1bIcst/+ x wild-type cross.
Age WT Icst/+ Total Pb
found dead at P0 7 18 25 0.028
found dead at P1 15 19 34 0.493
Live pups at P1a 61 41 102 0.048
a67 live pups observed at P0 missing at P1 (unknown genotype).
bTest for significance using Chi-square test.
doi:10.1371/journal.pgen.1004359.t003
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Materials and Methods
Ethics statement and animal husbandry
The animal studies described in this paper at the MRC Human
Genetics Unit were carried out under the guidance issued by the
Medical Research Council in Responsibility in the Use of Animals for
Medical Research (July 1993) and Home Office Project Licence
nos. PPL60/3124, PPL60/3785 and PPL60/4424. All experi-
ments conducted at The Jackson Laboratory were approved by the
institutional Animal Care and Use Committee. All animals were
treated in accordance with the protocols established by the
Association for Research in Vision and Ophthalmology. The
Jackson Laboratory’s pathogen surveillance program regularly
screened for pathogens. Mice were housed in a 14 hour light to
10 hour dark cycle. Mutant and littermate control mice were
housed together to control for cage-dependent differences. The
Lmx1bIcst strain has been submitted to the European Mouse
Mutant Archive (http://www. infrafrontier.eu) strain number
EM:00114. Both the Lmx1bIcst and knockout lines were maintained
on the C57BL/6J background. Clinical examinations were carried
out as previously described [18,48]. The BAC transgenic strain
was made as described [49].
Mutational analysis of Lmx1b
The exons and the immediate flanking sequences of Lmx1b were
amplified from Icst, BALB/c, C3H and C57BL/6J genomic DNA
using intronic primers that were also used for subsequent sequence
analysis. PCR products were purified using Millipore Multi-screen
PCR 96-well filtration system on a Biomek 2000 robotic platform
and sequenced directly using Big Dye terminator cycle sequencing.
Sequences were analysed using the Sequencher program.
Constructs and recombinant protein production
To produce N-terminally histidine-tagged fusion proteins of full-
length 372 amino acid LMX1B and the homeodomain alone,
wild-type and Icst cDNAs were amplified by PCR introducing Pci I
and Nco I sites at the 59 of the full-length and homeodomain
respectively and a Bam HI site at the 39 of both and cloned into
pGEM-T Easy (Promega). After digestion with BamHI and Pci I or
Nco I, as appropriate, the cDNAs were cloned into the Nco I and
Bam HI sites of pET6H [50]. Recombinant histidine-tagged
proteins were expressed in the Escherichia coli strain BL21 (DE3)
pLysS essentially as described [51]. Proteins were analysed by
sodium dodecyl sulphate–polyacrylamide gel electrophoresis to
Table 4. The transgenic BAC rescues the Icst heterozygous semi-lethal phenotype but not the homozygous lethal phenotype and
can rescue the knockout homozygous lethal phenotype.
Cross
Lmx1bIcst/+6Lmx1bIcst/+ [BAC] Lmx1bKO/+6Lmx1bKO/+ [BAC]
Genotype Number at weaning Genotype Number at weaning
WT [BAC] 14 WT [BAC] 22
WT 17 WT 23
Icst/+ [BAC] 24 KO/+ [BAC] 32
Icst/+ 19 KO/+ 35
Icst/Icst [BAC] 0 KO/KO [BAC] 3a
Icst/Icst 0 KO/KO 0
Pb 0.4129 Pb 0.2123
a11 pups that survived birth and had ventralised limbs died before weaning assumed to have this genotype.
bTest for significance using Chi-square test of the frequency of the first 4 genotypes.
doi:10.1371/journal.pgen.1004359.t004
Table 5. Homozygosity for the BAC transgene can rescue both the Icst and knockout lethal phenotypes.
Cross
Lmx1bIcst/+ [BAC62] intercross Lmx1bKO/+ [BAC62] intercross
Genotypea Number at weaning Genotypea Number at weaning
WT 22b WT 35
Icst/+ 44c KO/+ 78e
Icst/Icst 6d KO/KO 24f
Pg 0.0048 Pg 0.1107
For each cross the progeny from two matings was counted.
aall are homozygous for the transgenic BAC.
bincludes 1 taken for analysis before weaning.
cincludes 3 taken for analysis before weaning. There were 2 found dead on P0.
dincludes 5 taken for analysis before weaning. There were 4 that did not survive to weaning.
eincludes 2 taken for analysis before weaning. There was 1 found dead on P1.
fincludes 4 taken for analysis before weaning. There were 3 that that did not survive to weaning.
gTest for significance using Chi-square test.
doi:10.1371/journal.pgen.1004359.t005
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assess yield and purity and equal amounts of wild-type and mutant
proteins were used in bandshift experiments. For expression in
mammalian cells wild-type Lmx1b and Lmx1bIcst cDNAs were
cloned into the expression vector pcDNA3.1 (Invitrogen). The
original reported size of LMX1B protein is 372 amino acids [12].
An upstream in-frame ATG in the human sequence that would
encode an additional 23 amino acids has been reported [22]. This
sequence is conserved between mouse and human and the mouse
LMX1B protein sequence in the database has been revised to
include these extra 23 amino acids (entry O88609 in http://www.
uniprot.org). In addition, there is a direct duplication of 18 bp
encoding the first 6 amino acids of the 372 amino acid protein in
the mouse genome sequence that is not conserved in human. This
18 bp sequence has been found to be absent from some Lmx1b
cDNAs (e.g. BC125469) but it is found in the EST database
(BY741174.1). By RT-PCR we found it to be present in Lmx1b
transcripts (data not shown). We therefore made two versions of
LMX1B, one 372 amino acids long (-S) and one including the
additional N-terminal 29 amino acids (-L). Myc and FLAG-tagged
mammalian expression vectors were made using the Gateway
cloning system (Life Technologies). In brief, Lmx1bWT and
Lmx1bIcst were amplified from the -L constructs described above
and cloned into the donor vector pDONRTM221 (Life Technol-
ogies) and then into the destination vectors pcDNA3.1Myc-
HisDEST [52] and pDEST/C-SF-TAP [53] to give WT-Myc and
Icst-FLAG respectively following the manufacturer’s instructions.
Full-length Ldb1 was amplified from mouse embryonic cDNA
using primers that introduced a Hind III site at the 59 end and a
Bam HI site at the 39 end and cloned using these sites into
pcDNA3.1 (+) to give pcDNA-LDB1. All plasmids were verified by
sequencing.
Bandshift analysis
The FLAT probe from the Col4a4 gene intron 1 [21] was made
by annealing the two oligonucleotides 59-GGTTCATGAAAG-
TAATTATTTTCA-39 and 59-GGTTTGAAAATAATTACTT-
TCATG-39 and end-labelled by filling in the four base 59 single-
stranded extensions with 32P dATP and 32P dCTP using Klenow
polymerase. Bandshift analysis was carried out essentially as
described [54]. 20,000 cpm FLAT probe (,16107 cpm/mg
radiolabelled DNA probe) was used in each bandshift reaction.
Bacterial extract protein concentrations were ,5 mg/ml and we
used 1, 2 or 3 ml per reaction.
Transcription reporter assays
Transfections were carried out using a MicroPorator MP-100
following the manufacturer’s protocol (Microporator). To correct
for transfection efficiency and viability, 2.5 ng of renilla reporter
vector was also transfected. The day following transfection
luciferase assays were carried out using the Dual-luciferase
reporter assay system (Promega E1910) and readings were
normalised using the renilla reporter. Each experiment was
carried out in triplicate.
Mouse imaging
For anterior segment examination and photography, a Nikon
FS-3V zoom slit-lamp biomicroscope was used with an attached
Nikon D300S digital still camera and digital images were saved
using Adobe Photoshop CS5 (Adobe, Inc.). Mouse paws were
photographed using an imaging system comprising a Nikon
AZ100 macroscope (Nikon UK Ltd, Kingston-on-Thames, UK)
and a Qimaging Micropublisher 5 cooled colour camera
(Qimaging, Burnaby, BC). Image capture was performed using
in-house scripts written for IVision (BioVision Technologies,
Exton, PA).
Histology
Eye histology was carried out as previously described [18,48].
After dissection embryos were photographed and fixed overnight
in 4% paraformaldehyde in PBS at 4uC. A small part of the tail
was used for genotyping. After washing in PBS they were
dehydrated by immersion in a series of increasing concentrations
of alcohol, embedded in paraffin wax, sectioned and stained with
haematoxylin and eosin. Slides were viewed on a Leica MZFLIII
fluorescence stereo microscope fitted with a Coolsnap colour
Figure 6. Forepaw phenotype of transgenic rescue mice.
Pictures of the ventral and dorsal sides of forepaws from wild-type
(WT), Lmx1bIcst/Icst (Icst/Icst) and Lmx1bKO/KO (KO/KO) mice are shown
and whether the BAC transgene is hemizygous or homozygous is
indicated (BACx1 or BACx2). The ventral side of the paw is normal for all
the rescue mice. The dorsal surface of all the homozygous mutant paws
appears ventralised with pigmented footpads and no hair. The ages of
the mice shown are as follows. Top two rows, P14; third row P26 and
bottom row P35.
doi:10.1371/journal.pgen.1004359.g006
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camera (Roper Scientific, Tucson, Arizona, USA). Image capture
was controlled by in-house scripting of IPLab Spectrum
(Scanalytics, Fairfax, VA, USA). For plastic-based processing,
enucleated eyes were fixed (0.8% paraformaldehyde and 1.2%
glutaraldehyde in 0.08 M phosphate buffer (pH 7.4)) and
processed for plastic sectioning as previously described [48]. Serial
sagittal sections passing through the optic nerve were collected,
stained with hematoxylin and eosin, and analysed for pathologic
alterations.
Intraocular pressure measurements
For all mice, IOP was measured as previously described in detail
[55,56]. Briefly, mice were acclimatised to the procedure room
and anesthetized via an intraperitoneal injection of a mixture of
ketamine (99 mg/kg; Ketalar, Parke-Davis, Paramus, NJ) and
xylazine (9 mg/kg; Rompun, Phoenix Pharmaceutical, St. Joseph,
MO) prior to IOP assessment.
Ganglion cell counts
Eyes were collected into 26PBS and fixed in 2% paraformal-
dehyde in PBS for two minutes. After rinsing in 26PBS for five
minutes the retina was dissected and laid flat by making radial
incisions and fixed in methanol at 220uC for one hour. The
retinas were then fixed again in 4% paraformaldehyde in PBS for
five minutes, rinsed in 26PBS and blocked in wholemount buffer
(26PBS, 1% Cohn fraction BSA, 3% Triton X-100) for one hour
and then incubated with anti-BRN3 antibody (SC6026, Santa
Cruz) overnight. After three ten minutes washes in wholemount
buffer the retinas were incubated in Alexa Fluor 594 donkey anti-
goat secondary antibody (1/500) (Molecular Probes) in whole-
mount buffer for four hours. After three washes in wholemount
buffer, retinas were rinsed with 26PBS and post-fixed in 4%
paraformaldehyde in PBS for five minutes, mounted in Vecta-
shield hard set (Vector Labs). All washes and incubations were
carried out at room temperature on an orbital shaker. Four images
Figure 7. Forepaw skeletal phenotype of transgenic rescue mice. mCT scans of the ventral and dorsal sides from wild-type (WT), Lmx1bIcst/Icst
(Icst/Icst) and Lmx1bKO/KO (KO/KO) forepaws are shown and whether the BAC transgene is hemizygous or homozygous is indicated (BACx1 or BACx2).
The ventral side of the skeleton appears normal for all the rescue mice (top panels). The dorsal surface appears completely ventralised for the
Lmx1bIcst/Icst rescue mice homozygous for the transgene and for the Lmx1bKO/KO rescue hemizygous for the BAC transgene. Arrows point to sesamoid
bones that are a feature of the ventral surface. In the case of the Lmx1bKO/KO homozygous for the BAC transgene the dorsal surface appears more
normal although there are still aspects of ventral morphology seen, for example a sesamoid bone (arrowed). The images shown are from mice
between four and five weeks of age except for Lmx1bKO/KO hemizygous for the BAC transgene which was P26.
doi:10.1371/journal.pgen.1004359.g007
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were taken at 90u angles to each other around the optic disc using
the Nikon TiE-C1Si confocal microscope. The number of BRN3-
positive cells in each of the areas was counted using the Velocity
Image acquisition and analysis software (PerkinElmer, Waltham,
MA, USA). Mice from two litters were analysed. In the first litter
(age four months) two Lmx1bicst/+ mice were used and one each of
the other two genotypes. In the second litter (age one month) one
mouse of each genotype was used.
Assessment of optic nerve damage
Optic nerves were processed and analysed as previously
reported [48,57]. Briefly, nerves were stained with parapheny-
lene-diamine which differentially stains single damaged axons
allowing sensitive detection of axon injury. Nerves were deter-
mined to have one of three damage levels that are readily
distinguishable by axon counting.
Electron microscopy
E17.5 embryonic kidneys were fixed overnight in 3% glutaral-
dehyde in cacodylate buffer at 4uC then post-fixed in 1% osmium
tetroxide for two hours at 4uC. After dehydration through
ascending grades of alcohol and propylene oxide they were
impregnated with TAAB Embedding Resin (medium grade
premix) and cured for 24 hours. Ultrathin sections were stained
with uranyl acetate and lead citrate and viewed on a JEOL JEM
100CXII fitted with an AMT Digital Camera using the AMTv600
image capture software.
Skeletal imaging by mCT
Live animals and whole mount embryos and pups were scanned
using a Skyscan 1076 in vivo mCT system (Skyscan B.V., Aartselaar,
Belgium). Live animals were scanned under fluothane anaesthesia.
Animals were scanned at an isotropic resolution of 18.6 mm. Scans
were performed at 50 kV, 200 mA using a 0.5u rotation step and a
0.5 mm aluminium filter. Higher resolution scans of limbs were
performed using a Skyscan 1172 system at a resolution of 8.8 mm
(60 kV, 167 mA, 0.6u rotation step, 0.5 mm aluminium filter).
Scans were reconstructed using Skyscan NRecon software and
analysed using Skyscan CTAn software. Three dimensional
models were visualised using Skyscan CTVol software.
Co-immunoprecipitation
HEK 293T cells cultured in 100 mm dishes were transfected
with WT-Myc (5 mg), ICST-FLAG (2 mg), and pcDNA-LDB1
(5 mg) as indicated in a total of 12 mg DNA adjusted with
pcDNA3.1(-) as necessary using Lipofectamine LTX PLUS
(Invitrogen). After 48 hours the cells were lysed using Cell Lysis
Buffer (Cell Signaling Technology) and Myc-tagged complexes
immunoprecipitated using the Profound c-Myc Tag IP/Co-IP Kit
(Thermo Scientific) according to the manufacturer’s instructions.
Figure 8. Patella and scapula phenotype of transgenic rescue
mice. All mice shown are homozygous for the transgene. mCT scans of
the patella and scapula are shown. (A) Lmx1bIcst/+ (Icst/+) with normal
patella (arrowed). (B) Lmx1bIcst/Icst rescue (Icst/Icst) knee where the patella
is absent (arrow indicates its expected location). (C) Lmx1bKO/KO rescue
(KO/KO) knee where the patella is present (arrowed). (D) Normal scapula
in Lmx1bIcst/+ (arrowed). (E) The scapula is very underdeveloped and small
in Lmx1bIcst/Icst rescue (arrowed). (F) The scapula appears more normal in
Lmx1bKO/KO rescue (arrowed). The ages of the mice shown are as follows;
P23 (A, B, D, E), three months (C) and five weeks (F).
doi:10.1371/journal.pgen.1004359.g008
Figure 9. Wild-type and Icst LMX1B are in a complex with LDB1.
Western blot analysis of co-immunoprecipitation experiments using
anti-Myc (a-Myc), anti-FLAG (a-FLAG) and anti-LDB1 (a-LDB1) antibod-
ies. (A) Protein lysates (INPUT) of HEK 293T cells transfected with WT-
Myc and ICST-FLAG as indicated were immunoprecipitated using anti-c-
Myc antibody coupled to agarose and the bound fraction (BOUND)
eluted. WT-Myc is present in the immunoprecipitated bound fraction
but Icst-FLAG is not. (B) Protein lysates (INPUT) of HEK 293T cells
transfected with pcDNA-LDB1 along with WT-Myc and ICST-FLAG as
indicated were immunoprecipitated using anti-c-Myc agarose and the
bound fraction (BOUND) eluted. Both LDB1 and ICST-FLAG are in a
complex with the WT-Myc and found in the immunoprecipitated bound
fraction.
doi:10.1371/journal.pgen.1004359.g009
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Samples were separated on 4–12% NUPAGE gels (Life Technol-
ogies), transferred to Hybond-P (GE Healthcare) and probed with
anti-Myc (Cell Signaling Technology, #2276), anti-FLAG (Cell
Signaling Technology, #2368) and anti-LDB1(kind gift of Sam
Pfaff [58]) antibodies using standard protocols and visualised with
horseradish-peroxidase secondary antibody (GE Healthcare) and
SuperSignal West Pico Chemiluminescent Substrate (Thermo
Scientific) following the manufacturer’s instructions.
Statistical analysis
Values were expressed as mean+standard error and P,0.05 was
considered significant. For the data shown in Figure 1 a two-tailed
unpaired Student’s t-test was used for statistical analysis. For the
data shown in Figure 3 a two-tailed unequal variance t-test was
performed using JMP (http://www.jmp.com). For the ganglion
cell counts data shown in Figure 4 we used log transformation of
raw data to allow for a mean-variance relationship. We then tested
for a mean difference between replicate mice within genotype
using ANOVA. As replicate mice within genotype differed
significantly, we compared variation in mean cell count between
pairs of genotypes against variation between means of replicate
mice within genotype using a two-tailed Student’s t-test. For the
data shown in Tables 1–5 chi square tests were performed using
http://graphpad.com/quickcalcs.
Supporting Information
Figure S1 Icst homozygous phenotype. (A–B) mCT scans of
E18.5 embryos. In the wild-type (WT) the frontal (F), paretial (P),
interparietal (I) and occipital (O) bones are present. In Lmx1bIcst/Icst
(Icst/Icst) the frontal, paretial and interparietal bones are fused
(asterisk) and the occipital bone is missing (arrow). (C–D)
Haematoxylin and eosin staining of sagittal brain sections at
E16.5. The cerebellum is present in the wild-type (arrow) but
absent in Lmx1bIcst/Icst where the inferior colliculus connects
directly to the choroid plexus (asterisk). (E–F) Haematoxylin and
eosin staining of pupil-optic nerve sections through embryonic eyes
at E14.5. In Lmx1bIcst/Icst there is lens-corneal apposition. (G–H)
Haematoxylin and eosin staining of sections through the paw at
E18.5. Dorsal side is to the top. In the Lmx1bIcst/Icst paw there is
duplication of the ventral muscle pattern. Scale bar = 500 mm. (I–
J) Skeletal preparations of E18.5 hindlimbs. The patella is present
in the wild-type (arrow) but absent from the Lmx1bIcst/Icst knee
(arrow indicates its expected position).
(TIF)
Figure S2 Normal eye phenotype in Lmx1bIcst/+ heterozygous for
the transgenic BAC. Wild-type (WT) is shown on the left and
Lmx1bIcst/+ (Icst/+) is shown on the right. In both cases the mice are
hemizygous for the transgene ([BAC]). The gross eye phenotype is
shown in the top panels. Sections through the iridocorneal angle
are shown in the middle panels and sections through the cornea
are shown in the bottom panels. In all cases Lmx1bIcst/+ mice with
one copy of the transgene appear normal. Scale bar = 100 mm.
(TIF)
Figure S3 Eye phenotype of wild-type and homozygous
knockout mice hemizygous for the transgenic BAC. Wild-type
(WT) and Lmx1bKO/KO (KO/KO) hemizygous for the transgene
([BAC]) are shown. The external appearance, cornea and optic
nerve head of the eye is normal in most homozygous knockout
mice hemizygous for the transgenic BAC (middle panels) whereas
in some mice abnormalities are seen (right panels). In this case the
cornea has severe damage (middle panel, far right). Scale
bar = 100 mm.
(TIF)
Figure S4 Eye phenotype of rescue mice homozygous for the
transgenic BAC. (A) Lmx1bKO/KO (KO/KO) homozygous for the
transgene ([BAC/BAC]) eye phenotype range from normal (top
panels) to abnormal (middle and bottom panels). Sections through
the cornea and lens are shown on the left and sections through the
optic nerve are shown on the right. In the middle panels sections
through the abnormal eye of an Lmx1bKO/KO with one abnormal
eye are shown. The cornea appears thin and the optic nerve is
normal. In the bottom panels sections through an abnormal eye of
an Lmx1bKO/KO with two abnormal eyes are shown. The cornea is
thickened and abnormal but the optic nerve appears normal. (B)
Lmx1b expression from kidneys of Lmx1bKO/KO rescue mice with 0,
1 or 2 abnormal eyes. Lmx1b transcription is reduced in the
rescued mutant mice with 1 or 2 phenotypically abnormal eyes
compared to a rescued mutant mouse with normal eyes. Mean
values and standard error of three independent quantitative RT-
PCR reactions are shown. The expression of the sample with
normal eyes was set to one and the relative expression of the other
samples to this is shown. Experiment carried out as detailed in
Protocol S1. (C) Lmx1bIcst/Icst rescue mice display the mutant eye
phenotype in both eyes whereas BAC transgenic Lmx1bIcst/+ have
normal eyes. The transgene is homozygous ([BAC/BAC]).
Sections through the cornea and lens are shown on the left and
sections through the optic nerve are shown on the right. In the top
left panel tissue that appears to be contiguous with the cornea is
juxtaposed to the lens (arrowed) in Lmx1bIcst/Icst (Icst/Icst). The
Lmx1bIcst/+ (Icst/+) cornea shown in the bottom panel is normal.
There is cupping of the optic nerve in Lmx1bIcst/Icst (arrowed)
whereas the optic nerve of the Lmx1bIcst/+ is normal. Scale
bar = 100 mm.
(TIF)
Protocol S1 Real-time quantitative RT-PCR method.
(DOCX)
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